Category Press Releases

Poxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment

Poxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment POXEL SA (Euronext: POXEL – FR0012432516), a clinical-stage biopharmaceutical company specializing in innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic…

Read MorePoxel Secures New Patent in Japan for Imeglimin’s Use in Type 2 Diabetes Patients with Renal Impairment

Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence

Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence in North America Altasciences, a renowned leader in contract research and development, is proud to announce its recognition as the recipient of the 2025 CDMO Leadership Award in…

Read MoreAltasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Form Excellence

VeriSilicon Launches AcuityPercept: AI-Powered ISP Tuning System for Enhanced Imaging Performance

VeriSilicon Launches AcuityPercept: Revolutionizing AI-Powered ISP Tuning for Enhanced Vision Perception In an era where artificial intelligence (AI) is transforming industries, image signal processing (ISP) plays a pivotal role in enabling vision-based systems to deliver accurate and reliable results. VeriSilicon…

Read MoreVeriSilicon Launches AcuityPercept: AI-Powered ISP Tuning System for Enhanced Imaging Performance

Source Photonics Launches Industry-First 200G/Lane InP PIC for 1.6T IMDD Transceivers

Source Photonics Unveils Groundbreaking 200G/Lane InP PIC for 1.6T IMDD Transceivers: Revolutionizing Data Center Connectivity In today’s era of hyperscale data centers and AI-driven applications, the demand for high-speed, energy-efficient optical connectivity has never been greater. Source Photonics Inc., a…

Read MoreSource Photonics Launches Industry-First 200G/Lane InP PIC for 1.6T IMDD Transceivers

Tempus Presents 4 Abstracts at 2025 ACC Annual Meeting | Cardiology Innovations

Tempus AI to Present 4 Groundbreaking Abstracts at ACC 2025: Revolutionizing Cardiology with AI-Driven Insights Tempus AI, Inc. (NASDAQ: TEM), a trailblazer in leveraging artificial intelligence (AI) to enhance precision medicine and patient care, has announced its participation in the…

Read MoreTempus Presents 4 Abstracts at 2025 ACC Annual Meeting | Cardiology Innovations

Kay.ai Secures $3M to Revolutionize Insurance Operations by Automating Data Entry Tasks

Kay.ai Secures $3M to Revolutionize Insurance Operations with AI-Powered Automation The insurance industry is grappling with a growing workforce shortage, compounded by outdated systems and repetitive manual tasks that consume up to 80% of brokers’ time. To address this challenge,…

Read MoreKay.ai Secures $3M to Revolutionize Insurance Operations by Automating Data Entry Tasks

Sandbox VR Adds ‘Repeat Racers’ Mini-Game to Squid Game Virtuals for Season 2 Launch

Sandbox VR Expands Squid Game Virtuals with New “Repeat Racers” Mini-Game Ahead of Season 2 Launch In a move that combines cutting-edge virtual reality (VR) technology with the global phenomenon that is Squid Game, Sandbox VR, the world’s leading destination…

Read MoreSandbox VR Adds ‘Repeat Racers’ Mini-Game to Squid Game Virtuals for Season 2 Launch

SES and SpeQtral Partner to Drive Global Quantum-Secure Communication Solutions

SES and SpeQtral Partner to Advance Global Quantum-Secure Communications Through Interoperable Optical Ground Station In a groundbreaking move set to revolutionize global cybersecurity, SES, a leader in satellite-enabled connectivity solutions, and SpeQtral, a pioneer in space-based quantum technologies, have signed…

Read MoreSES and SpeQtral Partner to Drive Global Quantum-Secure Communication Solutions

ImmunoPrecise Antibodies (IPA) Announces Q3 FY2025 Financial Results and Key Business Updates

ImmunoPrecise Antibodies (IPA) Achieves Strategic Milestones and Reports Q3 FY2025 Financial Results ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced its financial results for the third quarter of fiscal year 2025 (Q3 FY2025), ended…

Read MoreImmunoPrecise Antibodies (IPA) Announces Q3 FY2025 Financial Results and Key Business Updates

Sectigo Wins 2025 Cybersecurity Award for Certificate Management & Leads in G2 Spring 2025 Reports

Sectigo Wins 2025 Cybersecurity Excellence Award for Certificate Lifecycle Management Leadership In a testament to its innovation and industry leadership, Sectigo, a global leader in digital certificates and automated Certificate Lifecycle Management (CLM), has been recognized with multiple prestigious awards…

Read MoreSectigo Wins 2025 Cybersecurity Award for Certificate Management & Leads in G2 Spring 2025 Reports

Thales and Cubic Team Up to Launch Cutting-Edge eSIM Solutions for Connected Vehicles

Thales and Cubic Partner to Revolutionize Connected Vehicle Solutions with Next-Gen eSIM Technology In a groundbreaking collaboration, Thales, a global leader in advanced technologies, and Cubic, a leading provider of software-defined vehicle (SDV) solutions, have joined forces to drive innovation…

Read MoreThales and Cubic Team Up to Launch Cutting-Edge eSIM Solutions for Connected Vehicles